Ariel Sponsors PancreasFest 2022

PancreasFest 2022

Ariel Precision Medicine was a featured speaker and supporter at PancreasFest 2022,  an annual forum where pancreatic leaders from across the world come together to discuss pancreatitis, CFTR- related diseases and pancreatic cancer research, discoveries and opportunities for improvement.

Jessica Gibson Named 2022 Pittsburgh Rising Founder, Inno Fire Award Honoree

Jessica Gibson, Co-Founder and CEO Ariel Precision Medicine

PITTSBURGH, Pa., July 26, 2022 Jessica Gibson, co-founder and CEO of Ariel Precision Medicine, was named a Rising Founder as part of the Pittsburgh Inno Fire Awards this week. She is part of an inaugural class of people and companies leading the region’s tech and innovation scene forward. The annual Fire Awards serve as Inno’s premier awards […]

Ariel is Named One of Pittsburgh Inno’s 2022 Startups to Watch

Downtown Pittsburgh, PA

Ariel joins other innovative startups including Agot AI, Apollo Neuroscience, Koop Technologies, Shift Robotics and others in Pittsburgh Inno’s 2022 Startups to Watch.   Ariel Precision Medicine Inc. was founded in 2015 by CEO Jessica Gibson, MBA, and Chief Scientific Officer David Whitcomb, MD, PhD.  Dr. Whitcomb is the Giant Eagle Foundation Professor of Cancer Genetics, […]

Ariel CEO & Co-Founder Jessica Gibson Featured in 2021 Women in Bio Founders Showcase

Jessica Gibson, Co-Founder/CEO, Ariel Precision Medicine was a keynote speaker in this year’s Women In Bio (WIB)-National: Second Annual Founders Showcase. The events showcases women founders or co-founders of life science start-up companies selected to deliver pitches to experts.  Jessica Gibson Co-Founder/CEO, Ariel Precision Medicine Ms. Gibson is CEO and Co-Founder of Ariel Precision Medicine, […]

Ariel Precision Medicine Expands Executive Team with Appointment of Dr. David C. Whitcomb as Chief Scientific Officer

Ariel Precision Medicine Expands Executive Team with Appointment of Dr. David C. Whitcomb as Chief Scientific Officer

Ariel Precision Medicine, Inc., has appointed Professor David C. Whitcomb, M.D. Ph.D. as chief scientific officer (CSO). Professor Whitcomb is a pioneer in the use of mathematics, genetics, genomics, cell biology, neurosciences, immunology and epidemiology to study complex inflammatory disorders and cancer risks of the digestive system. He co-founded Ariel Precision Medicine along with Jessica […]

Ariel Precision Medicine Receives Prestigious Award from Pittsburgh Technology Council

Ariel Precision Medicine has been named Innovator of the Year in the life sciences category by the Pittsburgh Technology Council. The council evaluated Ariel’s business accomplishments as well as its technological advancements, including the company’s flagship product, ADVANCE®, a cloud-based clinical decision support (CDS) tool designed to simplify the diagnosis and treatment of pancreatic disease.